Physician profile
Ward E Dawkins
NPI 1760653034
$5,737.96
in general payments reported to CMS, 2019-2025
9 companies · $402 in 2025
The $402 reported for 2025 was more than what 88% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,541 · 2020: $14.89 · 2021: $1,777 · 2022: $335 · 2023: $24.99 · 2024: $1,643 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $926 · Food and Beverage: $890 · Gift: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $926.04 |
| Food and Beverage | $890.16 |
| Gift | $253.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,672.63 | 2020-2025 | Primescan Connect, Cerec Tessera, Atlantis |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Patterson Companies, INC. | $1,393.84 | 2021-2024 | |
| Ultradent Products INC | $479.45 | 2021-2025 | Opalescence |
| Ivoclar Vivadent, INC. | $240.00 | 2021 | |
| Biohorizons Implant Systems INC. | $165.81 | 2021-2022 | |
| Straumann USA LLC | $165.43 | 2022-2025 | |
| Nobel Biocare USA | $71.03 | 2019-2021 | |
| Zimvie INC. | $49.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ward Dawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.